These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 646345)

  • 1. Diffusion disk susceptibility testing with cefaclor.
    Shadomy S; Carver M
    Antimicrob Agents Chemother; 1978 Feb; 13(2):228-33. PubMed ID: 646345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
    Shelton MM; Welch DF
    Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility studies with netilmicin: comparison of a 10-microgram netilmicin disk with a standardized 10-microgram gentamicin disk.
    Habwe V; Shadomy S
    Antimicrob Agents Chemother; 1978 Jun; 13(6):1046-8. PubMed ID: 98106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inability of cephalothin testing to predict cefprozil susceptibility.
    Fung-Tomc J; Stickle T; Doyle C; Huczko E; Kessler RE
    J Clin Microbiol; 1991 Nov; 29(11):2643-7. PubMed ID: 1774280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disk susceptibility studies with cefazolin and cephalothin.
    Actor P; Guarini J; Uri J; Dickson J; Pauls JF; Weisbach JA
    Antimicrob Agents Chemother; 1974 Jan; 5(1):63-7. PubMed ID: 4840450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies with cefaclor, a new oral cephalosporin.
    Sanders C
    Antimicrob Agents Chemother; 1977 Oct; 12(4):490-7. PubMed ID: 921244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies.
    Gray BM; Hubbell CA; Dillon HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):988-91. PubMed ID: 677865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of cefaclor, cefazolin, cefamandole, and cephalothin disks to predict susceptibility of Enterobacteriaceae, Staphylococcus species, and Haemophilus influenzae.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1985 Nov; 84(5):643-8. PubMed ID: 3877452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antibacterial spectra of cephalexin and cefaclor with those of cephalothin and newer cephalosporins: reevaluation of the class representative concept of susceptibility testing.
    Preston DA; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jun; 17(6):1156-8. PubMed ID: 6874906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autobac I procedure to assess susceptibility to Cefaclor.
    Gröschel D; Mills K; Hopfer RL
    J Clin Microbiol; 1980 Jun; 11(6):660-3. PubMed ID: 7430335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
    Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
    Doern GV; Jones RN; Gerlach EH; Hindler J; St Amand R
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):481-9. PubMed ID: 7957268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.
    Anderegg TR; Jones RN; Sader HS;
    J Clin Microbiol; 2004 Jul; 42(7):3356-8. PubMed ID: 15243116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.
    Barry AL; Schoenknecht FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Antimicrob Agents Chemother; 1979 Jan; 15(1):140-1. PubMed ID: 106770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1978; 18(2-3):85-90. PubMed ID: 624778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
    Friedland IR; Shelton S; McCracken GH
    J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.